BR112019023003A2 - vetor viral auto-inativante - Google Patents
vetor viral auto-inativante Download PDFInfo
- Publication number
- BR112019023003A2 BR112019023003A2 BR112019023003A BR112019023003A BR112019023003A2 BR 112019023003 A2 BR112019023003 A2 BR 112019023003A2 BR 112019023003 A BR112019023003 A BR 112019023003A BR 112019023003 A BR112019023003 A BR 112019023003A BR 112019023003 A2 BR112019023003 A2 BR 112019023003A2
- Authority
- BR
- Brazil
- Prior art keywords
- protein
- vector genome
- fact
- vector
- fraction
- Prior art date
Links
- 239000013603 viral vector Substances 0.000 title claims description 17
- 239000013598 vector Substances 0.000 claims abstract description 274
- 230000010076 replication Effects 0.000 claims abstract description 70
- 241000711798 Rabies lyssavirus Species 0.000 claims abstract description 46
- 241000711513 Mononegavirales Species 0.000 claims abstract description 31
- 108090000623 proteins and genes Proteins 0.000 claims description 316
- 102000004169 proteins and genes Human genes 0.000 claims description 219
- 210000004027 cell Anatomy 0.000 claims description 185
- 239000003795 chemical substances by application Substances 0.000 claims description 176
- 102100038132 Endogenous retrovirus group K member 6 Pro protein Human genes 0.000 claims description 128
- 230000002401 inhibitory effect Effects 0.000 claims description 87
- 230000001105 regulatory effect Effects 0.000 claims description 85
- 108010067390 Viral Proteins Proteins 0.000 claims description 81
- 230000014509 gene expression Effects 0.000 claims description 75
- 230000003213 activating effect Effects 0.000 claims description 72
- 101710091045 Envelope protein Proteins 0.000 claims description 69
- 101710188315 Protein X Proteins 0.000 claims description 69
- 238000000034 method Methods 0.000 claims description 66
- 108091005804 Peptidases Proteins 0.000 claims description 64
- 239000004365 Protease Substances 0.000 claims description 64
- 241000607479 Yersinia pestis Species 0.000 claims description 55
- 230000003612 virological effect Effects 0.000 claims description 54
- 210000002845 virion Anatomy 0.000 claims description 41
- 238000013518 transcription Methods 0.000 claims description 33
- 230000035897 transcription Effects 0.000 claims description 33
- 230000001939 inductive effect Effects 0.000 claims description 31
- 108020004707 nucleic acids Proteins 0.000 claims description 31
- 102000039446 nucleic acids Human genes 0.000 claims description 31
- 150000007523 nucleic acids Chemical class 0.000 claims description 31
- 239000003446 ligand Substances 0.000 claims description 27
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 24
- 102000004389 Ribonucleoproteins Human genes 0.000 claims description 22
- 108010081734 Ribonucleoproteins Proteins 0.000 claims description 22
- 101710141454 Nucleoprotein Proteins 0.000 claims description 18
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 claims description 18
- 125000000729 N-terminal amino-acid group Chemical group 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 16
- 238000004806 packaging method and process Methods 0.000 claims description 16
- 101710085938 Matrix protein Proteins 0.000 claims description 13
- 101710127721 Membrane protein Proteins 0.000 claims description 13
- 229910052757 nitrogen Inorganic materials 0.000 claims description 13
- 101710177166 Phosphoprotein Proteins 0.000 claims description 12
- 239000000411 inducer Substances 0.000 claims description 12
- 108020005004 Guide RNA Proteins 0.000 claims description 11
- 108010091086 Recombinases Proteins 0.000 claims description 11
- 108010042407 Endonucleases Proteins 0.000 claims description 10
- 101001065501 Escherichia phage MS2 Lysis protein Proteins 0.000 claims description 10
- 102000011931 Nucleoproteins Human genes 0.000 claims description 10
- 108010061100 Nucleoproteins Proteins 0.000 claims description 10
- 101710181008 P protein Proteins 0.000 claims description 10
- 102000018120 Recombinases Human genes 0.000 claims description 10
- 102100034574 P protein Human genes 0.000 claims description 9
- 229910052698 phosphorus Inorganic materials 0.000 claims description 9
- 239000003550 marker Substances 0.000 claims description 8
- 210000003061 neural cell Anatomy 0.000 claims description 8
- 108010013369 Enteropeptidase Proteins 0.000 claims description 7
- 102100029727 Enteropeptidase Human genes 0.000 claims description 7
- 108010074860 Factor Xa Proteins 0.000 claims description 7
- 108090000190 Thrombin Proteins 0.000 claims description 7
- 239000008194 pharmaceutical composition Substances 0.000 claims description 7
- 229960004072 thrombin Drugs 0.000 claims description 7
- 101710163270 Nuclease Proteins 0.000 claims description 6
- 230000008439 repair process Effects 0.000 claims description 6
- 229930192334 Auxin Natural products 0.000 claims description 4
- 108010003533 Viral Envelope Proteins Proteins 0.000 claims description 4
- 239000002363 auxin Substances 0.000 claims description 4
- 210000000805 cytoplasm Anatomy 0.000 claims description 4
- 230000028993 immune response Effects 0.000 claims description 4
- 230000000977 initiatory effect Effects 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 238000011282 treatment Methods 0.000 claims description 4
- 239000003937 drug carrier Substances 0.000 claims description 3
- 239000003022 immunostimulating agent Substances 0.000 claims description 3
- 239000003112 inhibitor Substances 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 2
- 102100031780 Endonuclease Human genes 0.000 claims 1
- 239000012190 activator Substances 0.000 claims 1
- 241000700605 Viruses Species 0.000 abstract description 137
- 231100000135 cytotoxicity Toxicity 0.000 abstract description 18
- 230000003013 cytotoxicity Effects 0.000 abstract description 18
- 235000018102 proteins Nutrition 0.000 description 196
- 210000002569 neuron Anatomy 0.000 description 85
- 206010037742 Rabies Diseases 0.000 description 73
- 208000015181 infectious disease Diseases 0.000 description 51
- 241000723792 Tobacco etch virus Species 0.000 description 31
- 230000015556 catabolic process Effects 0.000 description 23
- 238000006731 degradation reaction Methods 0.000 description 23
- 238000001727 in vivo Methods 0.000 description 21
- 230000006870 function Effects 0.000 description 20
- 210000001320 hippocampus Anatomy 0.000 description 19
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 18
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 16
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 16
- 241001465754 Metazoa Species 0.000 description 15
- 241000699670 Mus sp. Species 0.000 description 15
- 230000000694 effects Effects 0.000 description 15
- 230000001419 dependent effect Effects 0.000 description 13
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 13
- 229960002930 sirolimus Drugs 0.000 description 13
- 239000007924 injection Substances 0.000 description 12
- 238000002347 injection Methods 0.000 description 12
- 239000013612 plasmid Substances 0.000 description 12
- 230000004044 response Effects 0.000 description 12
- 230000029812 viral genome replication Effects 0.000 description 12
- 108091006027 G proteins Proteins 0.000 description 11
- 102000030782 GTP binding Human genes 0.000 description 11
- 108091000058 GTP-Binding Proteins 0.000 description 11
- 108090000288 Glycoproteins Proteins 0.000 description 11
- 102000003886 Glycoproteins Human genes 0.000 description 11
- 108090000708 Proteasome Endopeptidase Complex Proteins 0.000 description 11
- 102000004245 Proteasome Endopeptidase Complex Human genes 0.000 description 11
- 210000004899 c-terminal region Anatomy 0.000 description 11
- 230000006490 viral transcription Effects 0.000 description 11
- 208000002267 Anti-neutrophil cytoplasmic antibody-associated vasculitis Diseases 0.000 description 10
- 241001115070 Bornavirus Species 0.000 description 10
- 108091033409 CRISPR Proteins 0.000 description 10
- 241000711828 Lyssavirus Species 0.000 description 10
- 230000001687 destabilization Effects 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 230000007246 mechanism Effects 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 102000004533 Endonucleases Human genes 0.000 description 9
- 230000036982 action potential Effects 0.000 description 9
- 230000004048 modification Effects 0.000 description 9
- 238000012986 modification Methods 0.000 description 9
- 230000004083 survival effect Effects 0.000 description 9
- SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 description 8
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 8
- 241000711970 Vesiculovirus Species 0.000 description 8
- 229910002092 carbon dioxide Inorganic materials 0.000 description 8
- 229960003722 doxycycline Drugs 0.000 description 8
- 230000003834 intracellular effect Effects 0.000 description 8
- 108020004999 messenger RNA Proteins 0.000 description 8
- 108090000765 processed proteins & peptides Proteins 0.000 description 8
- 108091029795 Intergenic region Proteins 0.000 description 7
- 241000711975 Vesicular stomatitis virus Species 0.000 description 7
- 238000013461 design Methods 0.000 description 7
- 229940069417 doxy Drugs 0.000 description 7
- 239000003617 indole-3-acetic acid Substances 0.000 description 7
- 230000002458 infectious effect Effects 0.000 description 7
- 230000001537 neural effect Effects 0.000 description 7
- 210000001176 projection neuron Anatomy 0.000 description 7
- 230000006641 stabilisation Effects 0.000 description 7
- 238000011105 stabilization Methods 0.000 description 7
- 230000002103 transcriptional effect Effects 0.000 description 7
- 108010051219 Cre recombinase Proteins 0.000 description 6
- 241000712467 Cytorhabdovirus Species 0.000 description 6
- 239000004471 Glycine Substances 0.000 description 6
- 240000008415 Lactuca sativa Species 0.000 description 6
- 235000003228 Lactuca sativa Nutrition 0.000 description 6
- 101710154541 Modulator protein Proteins 0.000 description 6
- 241000287531 Psittacidae Species 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 230000002238 attenuated effect Effects 0.000 description 6
- 230000030833 cell death Effects 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 230000008685 targeting Effects 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 5
- 241000702421 Dependoparvovirus Species 0.000 description 5
- 241000713666 Lentivirus Species 0.000 description 5
- 241000124008 Mammalia Species 0.000 description 5
- 108090001074 Nucleocapsid Proteins Proteins 0.000 description 5
- 102000035195 Peptidases Human genes 0.000 description 5
- 102100027913 Peptidyl-prolyl cis-trans isomerase FKBP1A Human genes 0.000 description 5
- 102000007982 Phosphoproteins Human genes 0.000 description 5
- 108010089430 Phosphoproteins Proteins 0.000 description 5
- 108010006877 Tacrolimus Binding Protein 1A Proteins 0.000 description 5
- 150000001413 amino acids Chemical group 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 210000004556 brain Anatomy 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 230000000295 complement effect Effects 0.000 description 5
- HALQELOKLVRWRI-VDBOFHIQSA-N doxycycline hyclate Chemical group O.[Cl-].[Cl-].CCO.O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H]([NH+](C)C)[C@@H]1[C@H]2O.O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H]([NH+](C)C)[C@@H]1[C@H]2O HALQELOKLVRWRI-VDBOFHIQSA-N 0.000 description 5
- 230000002068 genetic effect Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 239000002773 nucleotide Substances 0.000 description 5
- 125000003729 nucleotide group Chemical group 0.000 description 5
- 230000017854 proteolysis Effects 0.000 description 5
- 230000006798 recombination Effects 0.000 description 5
- 238000005215 recombination Methods 0.000 description 5
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 238000011144 upstream manufacturing Methods 0.000 description 5
- 210000003462 vein Anatomy 0.000 description 5
- 230000000007 visual effect Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 241000283690 Bos taurus Species 0.000 description 4
- 208000000655 Distemper Diseases 0.000 description 4
- 241001455610 Ephemerovirus Species 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 241000712045 Morbillivirus Species 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 244000061176 Nicotiana tabacum Species 0.000 description 4
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 4
- 238000000692 Student's t-test Methods 0.000 description 4
- 108010076818 TEV protease Proteins 0.000 description 4
- 101150044379 TIR1 gene Proteins 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 210000004962 mammalian cell Anatomy 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000001404 mediated effect Effects 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 230000001338 necrotic effect Effects 0.000 description 4
- 230000006576 neuronal survival Effects 0.000 description 4
- RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 description 4
- 238000011002 quantification Methods 0.000 description 4
- 108020003175 receptors Proteins 0.000 description 4
- 102000005962 receptors Human genes 0.000 description 4
- 230000003362 replicative effect Effects 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- 208000003265 stomatitis Diseases 0.000 description 4
- 230000000946 synaptic effect Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000003363 transsynaptic effect Effects 0.000 description 4
- 208000005925 vesicular stomatitis Diseases 0.000 description 4
- 241000295638 Australian bat lyssavirus Species 0.000 description 3
- 241000884921 Bundibugyo ebolavirus Species 0.000 description 3
- 108091026890 Coding region Proteins 0.000 description 3
- 241000972395 Dichorhavirus Species 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 108060003393 Granulin Proteins 0.000 description 3
- 241000893570 Hendra henipavirus Species 0.000 description 3
- 241000035314 Henipavirus Species 0.000 description 3
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 3
- 241001112535 Novirhabdovirus Species 0.000 description 3
- 108700026244 Open Reading Frames Proteins 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- 241000986818 Perhabdovirus Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 241000287219 Serinus canaria Species 0.000 description 3
- 241000488874 Sonchus Species 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 108010046722 Thrombospondin 1 Proteins 0.000 description 3
- 102100036034 Thrombospondin-1 Human genes 0.000 description 3
- 102000044159 Ubiquitin Human genes 0.000 description 3
- 108090000848 Ubiquitin Proteins 0.000 description 3
- 108020000999 Viral RNA Proteins 0.000 description 3
- NMFHJNAPXOMSRX-PUPDPRJKSA-N [(1r)-3-(3,4-dimethoxyphenyl)-1-[3-(2-morpholin-4-ylethoxy)phenyl]propyl] (2s)-1-[(2s)-2-(3,4,5-trimethoxyphenyl)butanoyl]piperidine-2-carboxylate Chemical compound C([C@@H](OC(=O)[C@@H]1CCCCN1C(=O)[C@@H](CC)C=1C=C(OC)C(OC)=C(OC)C=1)C=1C=C(OCCN2CCOCC2)C=CC=1)CC1=CC=C(OC)C(OC)=C1 NMFHJNAPXOMSRX-PUPDPRJKSA-N 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- -1 chid Species 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 210000000172 cytosol Anatomy 0.000 description 3
- 230000000368 destabilizing effect Effects 0.000 description 3
- 238000006471 dimerization reaction Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 235000013601 eggs Nutrition 0.000 description 3
- 210000001671 embryonic stem cell Anatomy 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 238000013507 mapping Methods 0.000 description 3
- 210000004779 membrane envelope Anatomy 0.000 description 3
- 230000036403 neuro physiology Effects 0.000 description 3
- 230000004770 neurodegeneration Effects 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 230000003977 synaptic function Effects 0.000 description 3
- 230000002123 temporal effect Effects 0.000 description 3
- 230000005026 transcription initiation Effects 0.000 description 3
- 238000001890 transfection Methods 0.000 description 3
- 230000014616 translation Effects 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- RWVIMCIPOAXUDG-UHFFFAOYSA-N 6,7-dinitro-1,4-dihydroquinoxaline-2,3-dione Chemical compound N1C(=O)C(=O)NC2=C1C=C([N+](=O)[O-])C([N+]([O-])=O)=C2 RWVIMCIPOAXUDG-UHFFFAOYSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- 241000489724 Anphevirus Species 0.000 description 2
- 101000768857 Arabidopsis thaliana 3-phosphoshikimate 1-carboxyvinyltransferase, chloroplastic Proteins 0.000 description 2
- 241001550866 Aravan lyssavirus Species 0.000 description 2
- JQFZHHSQMKZLRU-IUCAKERBSA-N Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N JQFZHHSQMKZLRU-IUCAKERBSA-N 0.000 description 2
- 241000489718 Arlivirus Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000271566 Aves Species 0.000 description 2
- 241001520844 Borna disease virus 1 Species 0.000 description 2
- 241000711895 Bovine orthopneumovirus Species 0.000 description 2
- 241000712005 Bovine respirovirus 3 Species 0.000 description 2
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 2
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 2
- 241000282465 Canis Species 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 241000283153 Cetacea Species 0.000 description 2
- 241001597062 Channa argus Species 0.000 description 2
- 241001471269 Coastal Plains tibrovirus Species 0.000 description 2
- 101710094648 Coat protein Proteins 0.000 description 2
- 108091035707 Consensus sequence Proteins 0.000 description 2
- 241000252233 Cyprinus carpio Species 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 241000208296 Datura Species 0.000 description 2
- 101710088194 Dehydrogenase Proteins 0.000 description 2
- 241000716716 Drosophila affinis sigmavirus Species 0.000 description 2
- 241001488455 Drosophila ananassae sigmavirus Species 0.000 description 2
- 241001488446 Drosophila immigrans sigmavirus Species 0.000 description 2
- 241001497288 Drosophila melanogaster sigmavirus Species 0.000 description 2
- 241000689345 Drosophila obscura sigmavirus Species 0.000 description 2
- 241001488445 Drosophila tristis sigmavirus Species 0.000 description 2
- 241001520695 Duvenhage lyssavirus Species 0.000 description 2
- 241001115402 Ebolavirus Species 0.000 description 2
- 241000283073 Equus caballus Species 0.000 description 2
- 241000579695 European bat 1 lyssavirus Species 0.000 description 2
- 241000579698 European bat 2 lyssavirus Species 0.000 description 2
- 241000282324 Felis Species 0.000 description 2
- 101150082239 G gene Proteins 0.000 description 2
- 241000482313 Globodera ellingtonae Species 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- 241000711920 Human orthopneumovirus Species 0.000 description 2
- 241000712041 Human parainfluenza virus 4a Species 0.000 description 2
- 241000712036 Human parainfluenza virus 4b Species 0.000 description 2
- 241000711911 Human respiratory syncytial virus A2 Species 0.000 description 2
- 241000949113 Human respiratory syncytial virus S2 Species 0.000 description 2
- 241000712003 Human respirovirus 3 Species 0.000 description 2
- 241000430519 Human rhinovirus sp. Species 0.000 description 2
- 241001559187 Human rubulavirus 2 Species 0.000 description 2
- 241001058059 Irkut lyssavirus Species 0.000 description 2
- 241001109688 Isfahan virus Species 0.000 description 2
- 241000676396 Khujand lyssavirus Species 0.000 description 2
- 241001331012 Kotonkan virus Species 0.000 description 2
- 241001495929 Lishi Spider Virus 2 Species 0.000 description 2
- 241000439489 Lloviu cuevavirus Species 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241001559177 Mapuera rubulavirus Species 0.000 description 2
- 241000325689 Marava Species 0.000 description 2
- 240000004658 Medicago sativa Species 0.000 description 2
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 2
- 108060004795 Methyltransferase Proteins 0.000 description 2
- 241000725171 Mokola lyssavirus Species 0.000 description 2
- 208000005647 Mumps Diseases 0.000 description 2
- 241000581981 Muscina stabulans Species 0.000 description 2
- 241000456230 Mymonaviridae Species 0.000 description 2
- 241000526636 Nipah henipavirus Species 0.000 description 2
- 241000191474 Northern cereal mosaic cytorhabdovirus Species 0.000 description 2
- 241000468053 Obodhiang virus Species 0.000 description 2
- 241000277334 Oncorhynchus Species 0.000 description 2
- 241000233855 Orchidaceae Species 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 241000269799 Perca fluviatilis Species 0.000 description 2
- 241000711965 Piry virus Species 0.000 description 2
- 241000288906 Primates Species 0.000 description 2
- 108010026552 Proteome Proteins 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 241001115394 Reston ebolavirus Species 0.000 description 2
- 241000608027 Rice yellow stunt nucleorhabdovirus Species 0.000 description 2
- 239000008156 Ringer's lactate solution Substances 0.000 description 2
- 241000283984 Rodentia Species 0.000 description 2
- 241001533467 Rubulavirus Species 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- 241001559173 Simian rubulavirus Species 0.000 description 2
- 241000489722 Socyvirus Species 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 244000111146 Sonchus arvensis Species 0.000 description 2
- 235000008132 Sonchus arvensis ssp. uliginosus Nutrition 0.000 description 2
- 241001115376 Sudan ebolavirus Species 0.000 description 2
- 241001115374 Tai Forest ebolavirus Species 0.000 description 2
- 241000908303 Taro vein chlorosis nucleorhabdovirus Species 0.000 description 2
- 241000982619 Tibrovirus Species 0.000 description 2
- 108700009124 Transcription Initiation Site Proteins 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 241001329715 Tupaia virus Species 0.000 description 2
- 102000006275 Ubiquitin-Protein Ligases Human genes 0.000 description 2
- 108010083111 Ubiquitin-Protein Ligases Proteins 0.000 description 2
- 108700022715 Viral Proteases Proteins 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 150000001350 alkyl halides Chemical class 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 238000000540 analysis of variance Methods 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 108010062796 arginyllysine Proteins 0.000 description 2
- 238000013528 artificial neural network Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 208000005266 avian sarcoma Diseases 0.000 description 2
- 210000003050 axon Anatomy 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 210000003618 cortical neuron Anatomy 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000000763 evoking effect Effects 0.000 description 2
- 238000010304 firing Methods 0.000 description 2
- 235000019688 fish Nutrition 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000030279 gene silencing Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 230000000971 hippocampal effect Effects 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 230000002427 irreversible effect Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 208000021601 lentivirus infection Diseases 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 108010026228 mRNA guanylyltransferase Proteins 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 208000010805 mumps infectious disease Diseases 0.000 description 2
- 231100000989 no adverse effect Toxicity 0.000 description 2
- 238000001543 one-way ANOVA Methods 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 210000001428 peripheral nervous system Anatomy 0.000 description 2
- 230000002688 persistence Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000001242 postsynaptic effect Effects 0.000 description 2
- 230000020175 protein destabilization Effects 0.000 description 2
- 238000001243 protein synthesis Methods 0.000 description 2
- 229950010131 puromycin Drugs 0.000 description 2
- 230000007420 reactivation Effects 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 108010054624 red fluorescent protein Proteins 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 210000003625 skull Anatomy 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 210000004894 snout Anatomy 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 238000010361 transduction Methods 0.000 description 2
- 230000026683 transduction Effects 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 238000010798 ubiquitination Methods 0.000 description 2
- PRPINYUDVPFIRX-UHFFFAOYSA-N 1-naphthaleneacetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CC=CC2=C1 PRPINYUDVPFIRX-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- 108020005345 3' Untranslated Regions Proteins 0.000 description 1
- 108020003589 5' Untranslated Regions Proteins 0.000 description 1
- 239000013607 AAV vector Substances 0.000 description 1
- 102000003678 AMPA Receptors Human genes 0.000 description 1
- 108090000078 AMPA Receptors Proteins 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 108020005544 Antisense RNA Proteins 0.000 description 1
- 241001557960 Aquatic bird bornavirus 1 Species 0.000 description 1
- 241000487622 Aquatic bird bornavirus 2 Species 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 241001519465 Avian metapneumovirus Species 0.000 description 1
- 241000035315 Avulavirus Species 0.000 description 1
- 241000709756 Barley yellow dwarf virus Species 0.000 description 1
- 241000610275 Bean rugose mosaic virus Species 0.000 description 1
- 241001331006 Berrimah virus Species 0.000 description 1
- 241000776207 Bornaviridae Species 0.000 description 1
- 241000271511 Bothrops atrox Species 0.000 description 1
- 241001471248 Bovine fever ephemerovirus Species 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 244000308180 Brassica oleracea var. italica Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241001557990 Canary bornavirus 1 Species 0.000 description 1
- 241001557954 Canary bornavirus 2 Species 0.000 description 1
- 241001557962 Canary bornavirus 3 Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 101710132601 Capsid protein Proteins 0.000 description 1
- 241001481489 Carajas vesiculovirus Species 0.000 description 1
- 241000036569 Carp sprivivirus Species 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 102000011727 Caspases Human genes 0.000 description 1
- 108010076667 Caspases Proteins 0.000 description 1
- 108090000994 Catalytic RNA Proteins 0.000 description 1
- 102000053642 Catalytic RNA Human genes 0.000 description 1
- 241000173842 Celery mosaic virus Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241001481494 Chandipura vesiculovirus Species 0.000 description 1
- 241000489720 Chengtivirus Species 0.000 description 1
- 241001221360 Coffee ringspot dichorhavirus Species 0.000 description 1
- 244000205754 Colocasia esculenta Species 0.000 description 1
- 235000006481 Colocasia esculenta Nutrition 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 229920001651 Cyanoacrylate Polymers 0.000 description 1
- 102100033133 D-dopachrome decarboxylase Human genes 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- 241001474308 Datura yellow vein nucleorhabdovirus Species 0.000 description 1
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
- 241000274553 Eggplant mottled dwarf nucleorhabdovirus Species 0.000 description 1
- 241000468392 Elapid 1 bornavirus Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000521069 Ferlavirus Species 0.000 description 1
- 241000234642 Festuca Species 0.000 description 1
- 241000711950 Filoviridae Species 0.000 description 1
- 241001470863 Flanders hapavirus Species 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241001489698 Gerridae Species 0.000 description 1
- 241000148627 Hirame novirhabdovirus Species 0.000 description 1
- 101000927579 Homo sapiens D-dopachrome decarboxylase Proteins 0.000 description 1
- 101000958041 Homo sapiens Musculin Proteins 0.000 description 1
- 241000342334 Human metapneumovirus Species 0.000 description 1
- 241000726041 Human respirovirus 1 Species 0.000 description 1
- 101150010342 IAA17 gene Proteins 0.000 description 1
- 241000139260 Ikoma lyssavirus Species 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 241000711804 Infectious hematopoietic necrosis virus Species 0.000 description 1
- 101000668058 Infectious salmon anemia virus (isolate Atlantic salmon/Norway/810/9/99) RNA-directed RNA polymerase catalytic subunit Proteins 0.000 description 1
- 241000890148 Jerseyvirus Species 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- 125000002059 L-arginyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])C(=N[H])N([H])[H] 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 241000283953 Lagomorpha Species 0.000 description 1
- 241000191880 Lettuce big-vein associated varicosavirus Species 0.000 description 1
- 241000191478 Lettuce necrotic yellows cytorhabdovirus Species 0.000 description 1
- 241000766352 Maize Iranian mosaic nucleorhabdovirus Species 0.000 description 1
- 241000711937 Marburg marburgvirus Species 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 241000712079 Measles morbillivirus Species 0.000 description 1
- BJFJQOMZCSHBMY-YUMQZZPRSA-N Met-Val Chemical group CSCC[C@H](N)C(=O)N[C@@H](C(C)C)C(O)=O BJFJQOMZCSHBMY-YUMQZZPRSA-N 0.000 description 1
- 241001520531 Midway nyavirus Species 0.000 description 1
- 241000711386 Mumps virus Species 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000711941 Murine orthopneumovirus Species 0.000 description 1
- 101001041236 Mus musculus Ornithine decarboxylase Proteins 0.000 description 1
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 1
- 241000588650 Neisseria meningitidis Species 0.000 description 1
- 241001471094 Ngaingan hapavirus Species 0.000 description 1
- 241001520511 Nyamanini nyavirus Species 0.000 description 1
- 241000439378 Nyamiviridae Species 0.000 description 1
- 241000439380 Nyavirus Species 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 241001432884 Orthopneumovirus Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000269979 Paralichthys olivaceus Species 0.000 description 1
- 241000711504 Paramyxoviridae Species 0.000 description 1
- 241001611294 Parrot bornavirus 1 Species 0.000 description 1
- 241001611293 Parrot bornavirus 2 Species 0.000 description 1
- 241001611287 Parrot bornavirus 3 Species 0.000 description 1
- 241001611290 Parrot bornavirus 4 Species 0.000 description 1
- 241000488204 Parrot bornavirus 5 Species 0.000 description 1
- 241001611289 Parrot bornavirus 7 Species 0.000 description 1
- 241001611284 Passeriform 1 bornavirus Species 0.000 description 1
- 241001611286 Passeriform 2 bornavirus Species 0.000 description 1
- 241000288935 Platyrrhini Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000711904 Pneumoviridae Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000886268 Porcine respirovirus 1 Species 0.000 description 1
- 241000520007 Porcine rubulavirus Species 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 241000488201 Psittaciform 2 bornavirus Species 0.000 description 1
- 241000287530 Psittaciformes Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 108091034057 RNA (poly(A)) Proteins 0.000 description 1
- 108091030071 RNAI Proteins 0.000 description 1
- 101900236200 Rabies virus Nucleoprotein Proteins 0.000 description 1
- 101710151532 Replicating protein Proteins 0.000 description 1
- 241000489713 Reptile sunshinevirus 1 Species 0.000 description 1
- 241001113283 Respirovirus Species 0.000 description 1
- 241000711931 Rhabdoviridae Species 0.000 description 1
- 208000006257 Rinderpest Diseases 0.000 description 1
- 241000711897 Rinderpest morbillivirus Species 0.000 description 1
- 241000277263 Salmo Species 0.000 description 1
- 241000316146 Salmo trutta trutta Species 0.000 description 1
- 241000276448 Salvelinus namaycush Species 0.000 description 1
- 241000608094 Sanxia wastrivirus Species 0.000 description 1
- 241000456233 Sclerotinia sclerotimonavirus Species 0.000 description 1
- 241001100134 Sierra Nevada virus Species 0.000 description 1
- 206010040925 Skin striae Diseases 0.000 description 1
- 108020004459 Small interfering RNA Proteins 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 241000439329 Sprivivirus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 241000194020 Streptococcus thermophilus Species 0.000 description 1
- 208000031439 Striae Distensae Diseases 0.000 description 1
- 241000489711 Sunviridae Species 0.000 description 1
- 239000004830 Super Glue Substances 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 241000608083 Tacheng chengtivirus Species 0.000 description 1
- 108010027179 Tacrolimus Binding Proteins Proteins 0.000 description 1
- 102000018679 Tacrolimus Binding Proteins Human genes 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 241001125862 Tinca tinca Species 0.000 description 1
- 101710120037 Toxin CcdB Proteins 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 208000030886 Traumatic Brain injury Diseases 0.000 description 1
- 241000589892 Treponema denticola Species 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 241000802739 Tupanvirus Species 0.000 description 1
- 241000439025 Tupavirus Species 0.000 description 1
- 108091023045 Untranslated Region Proteins 0.000 description 1
- 241001230653 Varicosavirus Species 0.000 description 1
- 241000021394 Veia Species 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 241001517166 Vesicular stomatitis Alagoas virus Species 0.000 description 1
- 241000711973 Vesicular stomatitis Indiana virus Species 0.000 description 1
- 241000711959 Vesicular stomatitis New Jersey virus Species 0.000 description 1
- 206010058874 Viraemia Diseases 0.000 description 1
- 108700005077 Viral Genes Proteins 0.000 description 1
- 208000001449 Viral Hemorrhagic Septicemia Diseases 0.000 description 1
- 241000711825 Viral hemorrhagic septicemia virus Species 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 241001611285 Waterbird 1 bornavirus Species 0.000 description 1
- 241001531035 Wenzhou crustavirus Species 0.000 description 1
- 244000309507 Wheat American striate mosaic cytorhabdovirus Species 0.000 description 1
- 241001471098 Wongabel hapavirus Species 0.000 description 1
- 241001115400 Zaire ebolavirus Species 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000005875 antibody response Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000001640 apoptogenic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000010516 arginylation Effects 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229910002056 binary alloy Inorganic materials 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000005388 borosilicate glass Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 208000014058 canine distemper Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- PUXBGTOOZJQSKH-UHFFFAOYSA-N carprofen Chemical compound C1=C(Cl)C=C2C3=CC=C(C(C(O)=O)C)C=C3NC2=C1 PUXBGTOOZJQSKH-UHFFFAOYSA-N 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 230000006727 cell loss Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000036978 cell physiology Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000005889 cellular cytotoxicity Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000011260 co-administration Methods 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 238000007428 craniotomy Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 239000003479 dental cement Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 230000002900 effect on cell Effects 0.000 description 1
- 230000007831 electrophysiology Effects 0.000 description 1
- 238000002001 electrophysiology Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000001163 endosome Anatomy 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 108091006047 fluorescent proteins Proteins 0.000 description 1
- 102000034287 fluorescent proteins Human genes 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000009368 gene silencing by RNA Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 210000004295 hippocampal neuron Anatomy 0.000 description 1
- 102000046949 human MSC Human genes 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 230000003447 ipsilateral effect Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000034217 membrane fusion Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000000626 neurodegenerative effect Effects 0.000 description 1
- 210000004498 neuroglial cell Anatomy 0.000 description 1
- 230000007511 neuronal proliferation Effects 0.000 description 1
- 230000002276 neurotropic effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 210000005215 presynaptic neuron Anatomy 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000007115 recruitment Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
- 230000017610 release of virus from host Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000036390 resting membrane potential Effects 0.000 description 1
- 230000001177 retroviral effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
- 229940099315 rimadyl Drugs 0.000 description 1
- 102200015453 rs121912293 Human genes 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 229910052594 sapphire Inorganic materials 0.000 description 1
- 239000010980 sapphire Substances 0.000 description 1
- 210000001044 sensory neuron Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000008354 sodium chloride injection Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 101150065190 term gene Proteins 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000005030 transcription termination Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000010474 transient expression Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 108091005703 transmembrane proteins Proteins 0.000 description 1
- 102000035160 transmembrane proteins Human genes 0.000 description 1
- 230000009529 traumatic brain injury Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000005199 ultracentrifugation Methods 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000006656 viral protein synthesis Effects 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/145—Rhabdoviridae, e.g. rabies virus, Duvenhage virus, Mokola virus or vesicular stomatitis virus
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
- A01K2217/052—Animals comprising random inserted nucleic acids (transgenic) inducing gain of function
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/20—Animal model comprising regulated expression system
- A01K2217/206—Animal model comprising tissue-specific expression system, e.g. tissue specific expression of transgene, of Cre recombinase
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0393—Animal model comprising a reporter system for screening tests
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/95—Fusion polypeptide containing a motif/fusion for degradation (ubiquitin fusions, PEST sequence)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20141—Use of virus, viral particle or viral elements as a vector
- C12N2760/20143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
- C12N2810/60—Vectors comprising as targeting moiety peptide derived from defined protein from viruses
- C12N2810/609—Vectors comprising as targeting moiety peptide derived from defined protein from viruses positive strand RNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1706945.1A GB201706945D0 (en) | 2017-05-02 | 2017-05-02 | Self-inactivating viral vector |
| PCT/GB2018/051166 WO2018203049A1 (en) | 2017-05-02 | 2018-05-02 | Self-inactivating viral vector |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112019023003A2 true BR112019023003A2 (pt) | 2020-05-19 |
Family
ID=59011153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112019023003A BR112019023003A2 (pt) | 2017-05-02 | 2018-05-02 | vetor viral auto-inativante |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12203092B2 (https=) |
| EP (1) | EP3619314B1 (https=) |
| JP (1) | JP7420558B2 (https=) |
| KR (1) | KR20200015900A (https=) |
| CN (1) | CN110914439B (https=) |
| AU (1) | AU2018262281B2 (https=) |
| BR (1) | BR112019023003A2 (https=) |
| CA (1) | CA3060675A1 (https=) |
| GB (1) | GB201706945D0 (https=) |
| WO (1) | WO2018203049A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021004389A1 (zh) * | 2019-07-05 | 2021-01-14 | 司龙龙 | 蛋白水解靶向病毒、其活疫苗及其制备方法和用途 |
| CA3208612A1 (en) * | 2021-02-19 | 2022-08-25 | Beam Therapeutics Inc. | Recombinant rabies viruses for gene therapy |
| AU2022264328A1 (en) * | 2021-04-27 | 2023-11-16 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Recombinant cedar virus chimeras |
| CN115704012A (zh) * | 2021-08-12 | 2023-02-17 | 中国科学院深圳先进技术研究院 | 一种含有降解决定子的重组病毒及其制备方法和应用 |
| CA3230629A1 (en) * | 2021-09-08 | 2023-03-16 | Beam Therapeutics Inc. | Viral guide rna delivery |
| CN116262911B (zh) * | 2021-12-14 | 2026-02-17 | 中国科学院深圳先进技术研究院 | 一种减毒、复制可控的顺向hsv示踪系统及其构建方法和应用 |
| CN114058641B (zh) * | 2022-01-17 | 2022-04-01 | 苏州大学 | 一种载体系统和应用及通过其降解目的蛋白的方法 |
| CN116676273A (zh) * | 2022-02-22 | 2023-09-01 | 中国科学院深圳先进技术研究院 | 一种蛋白水解靶向流感病毒及其制备方法和应用 |
| CN120366391A (zh) * | 2023-04-18 | 2025-07-25 | 上海本导基因技术有限公司 | 一种用于治疗亨廷顿疾病的慢病毒样颗粒 |
| CN117867029B (zh) * | 2023-12-29 | 2024-12-20 | 复百澳(苏州)生物医药科技有限公司 | 一种狂犬亚型假病毒的制备方法及应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0500722A2 (hu) * | 2001-07-20 | 2005-11-28 | The University of Georgia Research Foundation, Inc@Á | Attenuált veszettség vírus, a veszettség elleni vakcináláshoz és a központi idegrendszer génterápiájához egy nukleoprotein mutációval a foszforilezés helyén |
| US7608682B2 (en) | 2002-10-30 | 2009-10-27 | Meso Scale Technologies Llc | Substrates of N-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrates |
| US9212359B2 (en) | 2011-06-23 | 2015-12-15 | Sanford Jay Silverman | Systems for induction of gene expression and protein depletion in yeast |
| US20180195085A1 (en) | 2015-02-02 | 2018-07-12 | Id Pharma Co., Ltd. | Improved negative-strand rna viral vector |
| US10550379B2 (en) * | 2015-06-29 | 2020-02-04 | The Board Of Trustees Of The Leland Stanford Junior University | Degron fusion constructs and methods for controlling protein production |
-
2017
- 2017-05-02 GB GBGB1706945.1A patent/GB201706945D0/en not_active Ceased
-
2018
- 2018-05-02 EP EP18723917.3A patent/EP3619314B1/en active Active
- 2018-05-02 US US16/607,980 patent/US12203092B2/en active Active
- 2018-05-02 JP JP2019560380A patent/JP7420558B2/ja active Active
- 2018-05-02 AU AU2018262281A patent/AU2018262281B2/en active Active
- 2018-05-02 CN CN201880029221.8A patent/CN110914439B/zh active Active
- 2018-05-02 BR BR112019023003A patent/BR112019023003A2/pt not_active Application Discontinuation
- 2018-05-02 WO PCT/GB2018/051166 patent/WO2018203049A1/en not_active Ceased
- 2018-05-02 KR KR1020197035530A patent/KR20200015900A/ko not_active Withdrawn
- 2018-05-02 CA CA3060675A patent/CA3060675A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US12203092B2 (en) | 2025-01-21 |
| CN110914439A (zh) | 2020-03-24 |
| KR20200015900A (ko) | 2020-02-13 |
| CA3060675A1 (en) | 2018-11-08 |
| EP3619314A1 (en) | 2020-03-11 |
| WO2018203049A1 (en) | 2018-11-08 |
| GB201706945D0 (en) | 2017-06-14 |
| EP3619314B1 (en) | 2021-11-10 |
| CN110914439B (zh) | 2024-05-17 |
| AU2018262281A1 (en) | 2019-11-14 |
| AU2018262281B2 (en) | 2024-05-09 |
| JP2020518265A (ja) | 2020-06-25 |
| JP7420558B2 (ja) | 2024-01-23 |
| US20210115472A1 (en) | 2021-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112019023003A2 (pt) | vetor viral auto-inativante | |
| ES2981970T3 (es) | Expresión transgénica selectiva de tejidos | |
| AU2014227600B2 (en) | Optogenetic control of behavioral state | |
| ES2741502T3 (es) | Cápside de AAV8 modificada para la transferencia génica para terapias de retina | |
| US9636380B2 (en) | Optogenetic control of inputs to the ventral tegmental area | |
| BR112021013996A2 (pt) | Terapia gênica mediada por aav que recupera o gene otoferlina | |
| Leclere et al. | Impaired axonal regeneration by isolectin B4-binding dorsal root ganglion neurons in vitro | |
| ES2924521T3 (es) | Vectores del VHS para la administración de NT3, y tratamiento de la CIPN | |
| JP2016530253A (ja) | ＬＣＡ−８及び進行性ＲＰを治療するための組換えＡＡＶ−Ｃｒｕｍｂｓホモログ組成物及び方法 | |
| WO2023077138A1 (en) | Compositions and systems for rna-programable cell editing and methods of making and using same | |
| KR20230169427A (ko) | 개선된 광 민감성을 갖는 채널옵신 변이체에서의 돌연변이의 확인 및 이의 용도 | |
| Lu et al. | Cholinergic Grb2-associated-binding protein 1 regulates cognitive function | |
| US12351812B2 (en) | Recombinant oncolytic virus | |
| CN118922541A (zh) | 用于rna可编程细胞编辑的组合物和系统及其制备和使用方法 | |
| Stieglitz | The control of neuronal activity and behavior by members of the HCN and TPC family | |
| Groutsi | Highly disabled Herpes Simplex Virus 1 vectors: Applications in CNS regeneration with emphasis on the chronically injured spinal cord | |
| Deng | The development of coxsackievirus type B3 as a novel oncolytic virus against KRAS-mutant non-small-cell lung cancer | |
| Park | VRPD Novel Combinatory Approaches to Repair Visual System After Optic Nerve Damage | |
| Daniels | The role of growth associated proteins in axon sprouting after stroke | |
| Levin | Muscle Lim Protein in naïve and injured neurons | |
| Kolstad | Development and assessment of gene therapies for inherited blinding diseases | |
| Weitz et al. | Imaging the retina's response to electrical stimulation with genetically encoded calcium indicators | |
| Sonnemann | Generation and characterization of new mouse models and potential therapies for diseases of striated muscle | |
| James | Static and Dynamic Aspects of Olfactory Processing Circuits | |
| Greenberg | Development of targeted gene therapy vectors for retinal disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |